Bausch Health Companies Inc. BHC

BHC Company Overview

Bausch Health Companies Inc. is a diversified healthcare company focused on pharmaceuticals, medical devices, and over-the-counter consumer health products. The company operates primarily in the branded and generic pharmaceutical industries, with significant activities in gastroenterology, ophthalmology, dermatology, neurology, and aesthetic medicine. Bausch Health generates revenue through prescription drug sales, eye health products, surgical devices, and consumer healthcare brands distributed across global markets. Its portfolio includes both patented and established products, with a strategy centered on specialty healthcare categories where it maintains recognized market positions.

The company traces its origins to Valeant Pharmaceuticals International, which expanded aggressively through acquisitions during the 2000s and early 2010s. Following governance controversies, pricing scrutiny, and substantial debt accumulation, the company rebranded as Bausch Health Companies Inc. in 2018 to align more closely with its core healthcare businesses and restore strategic focus. A major milestone in its evolution was the separation and public listing of Bausch + Lomb, which became an independent publicly traded eye health company while remaining strategically connected through ownership and operational history.